PNC Financial Services Group’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.4K Buy
830
+90
+12% +$991 ﹤0.01% 3983
2025
Q4
$5.93K Sell
740
-2,174
-75% -$50.8K ﹤0.01% 4161
2025
Q3
$140K Buy
+2,914
New +$64.7K ﹤0.01% 2560
2023
Q4
Sell
-20
Closed -$370 4702
2023
Q3
$370 Hold
20
﹤0.01% 4491
2023
Q2
$346 Hold
20
﹤0.01% 4626
2023
Q1
$503 Buy
+20
New +$2.28K ﹤0.01% 4525
2022
Q2
Sell
-4
Closed 4616
2022
Q1
$0 Buy
+4
New +$764 ﹤0.01% 4622
2021
Q4
Sell
-2
Closed -$1K 4533
2021
Q3
$1K Buy
+2
New +$787 ﹤0.01% 4204
2021
Q2
Sell
-4
Closed -$2K 4240
2021
Q1
$2K Buy
+4
New +$7.77K ﹤0.01% 3957

Other funds holding KRRO

PNC Financial Services Group's KRRO Position: Q1 2026 in Review

PNC Financial Services Group increased its Korro Bio (KRRO) stake by 12% in Q1 2026, buying an estimated $991 and bringing the position to 830 shares worth $9.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3983.

PNC Financial Services Group first reported a position in KRRO in Q1 2021 and has held it in 9 quarters since. The position peaked at $140K in Q3 2025. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • PNC Financial Services Group held 830 shares of Korro Bio worth $9.4K as of Q1 2026.
  • PNC Financial Services Group bought 90 Korro Bio shares in Q1 2026, an estimated $991.
  • Korro Bio made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3983 holding.
  • PNC Financial Services Group first reported a position in Korro Bio in Q1 2021 and has held it in 9 quarters since.
  • PNC Financial Services Group's Korro Bio position peaked at $140K in Q3 2025.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.